Overview
What is Institute For Myeloma & Bone Cancer Research?
The Institute for Myeloma & Bone Cancer Research is a nonprofit organization situated in West Hollywood, California. Its primary mission is to conduct research into the causes of myeloma, bone cancer, and related disorders, and to develop therapies for their treatment and control. The institute also aims to prevent the development of these conditions, including providing treatment for affected individuals. With a team of seven dedicated professionals, the Institute for Myeloma & Bone Cancer Research has made significant strides in advancing research and therapies for myeloma and bone cancer, contributing to potential cures and reduced occurrences of these diseases.
Official website here: www.imbcr.org
Is Institute For Myeloma & Bone Cancer Research legitimate?
Institute For Myeloma & Bone Cancer Research is a legitimate nonprofit organization registered as a 501(c)(3) entity. Institute For Myeloma & Bone Cancer Research submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $312,133
For more financial information, click here
Official website here: www.imbcr.org
What is the mission statement of Institute For Myeloma & Bone Cancer Research?
The Institute for Myeloma & Bone Cancer Research was established with a mission to promote research into the causes of myeloma, bone cancer, and related disorders. Its primary goal is to support the development of therapies designed to treat and control these diseases. Additionally, the institute aims to advance efforts directed at preventing the development of these disorders, including the treatment of individuals affected by them. The organization's major activities include conducting research related to the causes of myeloma and related disorders and developing therapies to prevent and treat these conditions.
Official website here: www.imbcr.org
What is the revenue of Institute For Myeloma & Bone Cancer Research?
Institute For Myeloma & Bone Cancer Research's revenue in 2024 was $2,137,198.
Official website here: www.imbcr.org
Who are the executives of Institute For Myeloma & Bone Cancer Research and what are their salaries?
The average compensation at Institute For Myeloma & Bone Cancer Research during 2024 was $62,427. There are 5 employees and 5 volunteers at Institute For Myeloma & Bone Cancer Research.
Here are 13 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.imbcr.org
Where can I find the form 990 for Institute For Myeloma & Bone Cancer Research?
Institute For Myeloma & Bone Cancer Research's most recent form 990 was submitted in 2024 and can be accessed here.
Official website here: www.imbcr.org
Learn more at the official website: www.imbcr.org
Mission Statement of Institute For Myeloma & Bone Cancer Research
The Institute for Myeloma & Bone Cancer Research is established with a threefold mission. Primarily, the organization aims to promote research into the causes of myeloma, bone cancer, and related disorders. This research is crucial in gaining a deeper understanding of these diseases, which can lead to the development of more effective treatments.
Secondly, the Institute supports the creation of therapies designed to treat and control myeloma, bone cancer, and related disorders. By investing in research and development, the Institute seeks to provide hope to those suffering from these diseases.
Lastly, the Institute is committed to preventing the development of myeloma, bone cancer, and related disorders, including the treatment of individuals already diagnosed with these diseases. This aspect of their mission involves advancing efforts in this field, with the ultimate goal of reducing the incidence and impact of these diseases on people's lives. The Institute's major activities will primarily focus on research related to the causes of myeloma and related disorders, as well as the development of therapies to prevent and treat myeloma and related disorders.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Institute for Myeloma & Bone Cancer Research significantly impacts the medical community and patients through its commitment to advancing research and treatment for myeloma and related disorders. It focuses on three key areas: promoting research into the underlying causes of these diseases, supporting the development of effective therapies, and preventing the onset of myeloma and bone cancer.
Through its research initiatives, the Institute has made notable advancements in understanding myeloma, leading to improved treatments that can either cure or significantly reduce the occurrence of this condition in patients. This not only enhances the quality of life for those affected but also contributes to the broader fight against cancer diseases. By fostering innovative therapies, the Institute actively collaborates with scientists and healthcare professionals, pushing the boundaries of current medical knowledge and practice.
By prioritizing both research and preventative strategies, the Institute plays a vital role in transforming the landscape of care for individuals facing myeloma and related disorders, ultimately saving lives and improving health outcomes.
This information is meant to be a general summary of Institute For Myeloma & Bone Cancer Research. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2024.
- Investment Income: $1
- Program Service Revenue: $121,761
- Gross Receipts: $2,137,198
Assets and Liabilities:
- Total Assets: $660,470
- Total Liabilities: $2,798,157
- Net Assets: -$2,137,687
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
SERVICE INCOME - BLOOD
Revenue
$72,697
RESEARCH SERVICE REVENUE
Revenue
$49,064
Organization Details
Founding Year
2002
Principal Officer
James R Berenson Md
Website
www.imbcr.orgNTEE Category
Code: G30 - Disease
If you are a representative of Institute For Myeloma & Bone Cancer Research and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.